News

The data were presented by Alan Cross, professor of medicine and Subhendu Basu, assistant professor at University of Maryland School of Medicine. Valortim is a fully human anti-toxin

According to the interim analysis the safety profile was similar between the treatment and placebo arms. Based on a composite efficacy endpoint assessing time to treatment failure (including

Stirling was contracted for this clinical trial in late January 2010 and patient recruitment has already commenced and will continue through March 2010. The study will be conducted

The move positions Community Research to offer clinical trials to US sponsors with a combination of safety (the hospital-based clinical research unit) and independence (privately owned and operated

In the Phase III clinical study conducted over three years with more than 4,000 males ages 16 to 26, the quadrivalent HPV vaccine was 89.4% efficacious in reducing

Epigenomics’ diagnostic test is being developed as an aid in diagnosis for lung cancer and may help pathologists to confirm the diagnosis of malignant lung disease when current

Under the terms of the agreement, Basilea will receive an upfront payment of CHF75m and will be eligible to receive up to CHF478m in additional payments on achievement

Developed based on MedNet’s extensive, decade-long experience supporting world-wide clinical trials and registries, iMedNet is a Web 2.0-based EDC solution built using advanced technology tools available. MedNet claimed

LIPO-102 is a new, minimally-invasive, non-ablative approach to localised fat reduction comprising an injectable aqueous combination of salmeterol xinafoate (SX) and fluticasone propionate (FP). Injection of LIPO-102 is